Aminoguanidine Pyridoxal Adduct Is Superior to Aminoguanidine for Preventing Diabetic Nephropathy in Mice

Hormone and Metabolic Research - Germany
doi 10.1055/s-2002-33478
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Correction: Aminoguanidine Teatment Inhibits the Development of Experimental Diabetic Retinopathy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Aminoguanidine Treatment Inhibits the Development of Experimental Diabetic Retinopathy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Aminoguanidine Does Not Inhibit the Initial Phase of Experimental Diabetic Retinopathy in Rats

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1995English

Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
1992English

Aminoguanidine Inhibits the Development of Accelerated Diabetic Retinopathy in the Spontaneous Hypertensive Rat

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1994English

Nickel Compounds of Aminoguanidine, Diaminoguanidine, and Triaminoguanidine.

Acta Chemica Scandinavica
1949English

Effect of Sub-Chronic Intraperitoneal Administration of Aminoguanidine on the Memory and Hippocampal Apoptosis-Related Genes in Diabetic Rats

Bratislava Medical Journal
2016English

Aminoguanidine and Aortic Wall Mechanics, Structure, and Composition in Aged Rats

Hypertension
Internal Medicine
2001English

TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE-/- Mice

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy